United States-based Abbott (NYSE: ABT) announced on Thursday that its board of directors has declared its quarterly common dividend of USD0.47 per share.
The dividend will be paid to shareholders of record at 14 October 2022 on 15 November 2022.
This marks the 395th consecutive quarterly dividend to be paid by Abbott since 1924.
Abbott is a global healthcare company with a portfolio including products in diagnostics, medical devices, nutritionals and branded generic medicines.
ANI Pharmaceuticals Receives FDA Approval, Launches Fluoxetine Oral Solution USP
ANI Pharmaceuticals receives FDA approval for Fluoxetine Oral Solution USP
Prasco Laboratories introduces Authorised Generic of ZIOPTAN in partnership with Thea Pharma
ANI Pharmaceuticals declares FDA approval and commercialisation of Trimethoprim Tablets USP
McKinley, Boothe Named to Maxwell Biosciences Board of Directors
Glenmark Pharmaceuticals USA launches Fingolimod Capsules, 0.5 mg in US
BizCap Secures USD 45m Credit Facility for Nivagen Pharmaceuticals
EpiVax receives USD2m grant to study immunogenicity risk evaluation of host cell proteins
Avacta Launches Phase I Clinical Study of AVA6000 to Advance to the Fourth Cohort
Avacta receives ODD from US Food and Drug Administration for AVA6000 to treat soft tissue sarcoma
Lannett completes participant dosing in biosimilar insulin glargine pivotal clinical trial